微笑: OC(CCSC[C@@H]1[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]4[C@H](O)[C@@H](O)[C@H](O5)[C@@H](CSCCC(O)=O)O4)[C@@H](CSCCC(O)=O)O3)[C@@H](CSCCC(O)=O)O2)[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@@H]7[C@@H](CSCCC(O)=O)O[C@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)[C@@H]5O[C@@H]9CSCCC(O)=O)O[C@@H]8CSCCC(OC)=O)[C@H](O)[C@H]7O)O[C@@H]6CSCCC(O)=O)O1)=O
印地语: InChI=1S/C74H116O48S8/c1-2-106-42(89)10-18-130-26-34-66-50(97)58(105)74(114-34)121-65-33(25-129-17-9-41(87)88)112-72(56(103)48(65)95)119-63-31(23-127-15-7-39(83)84)110-70(54(101)46(63)93)117-61-29(21-125-13-5-37(79)80)108-68(52(99)44(61)91)115-59-27(19-123-11-3-35(75)76)107-67(51(98)43(59)90)116-60-28(20-124-12-4-36(77)78)109-69(53(100)45(60)92)118-62-30(22-126-14-6-38(81)82)111-71(55(102)47(62)94)120-64-32(24-128-16-8-40(85)86)113-73(122-66)57(104)49(64)96/h27-34,43-74,90-105H,2-26H2,1H3,(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88)/t27-,28-,29-,30-,31-,32-,33-,34-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-/m1/s1
Analytical method development and validation for the estimation of sugammadex
By Parekh, Hemangi; Chokshi, Parin; Mashru, Rajashree
From Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.
Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H
From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.